| Members |
targetComponentId |
| Rinne's test positive |
Rinne's test positive (finding) |
| Risk factors in pregnancy NOS |
Antenatal risk factors (situation) |
| Risk factors in pregnancy NOS |
Antenatal risk factors (situation) |
| rituell kvinnlig omskärelse |
Female genital mutilation |
| rituell kirurgisk åtgärd |
Ritual circumcision |
| Ritual surgery |
Ritual circumcision |
| Ritual surgery NOS |
Ritual circumcision |
| Ritual surgery NOS |
Ritual circumcision |
| Rituximab 100mg infusion concentrate vial |
Rituximab 10 mg/mL solution for injection |
| Rituximab 100mg injection |
Rituximab 10 mg/mL solution for injection |
| rituximab 10 mg/ml, infusionskoncentrat, flaska 50 ml |
Rituximab 10 mg/mL solution for injection |
| rituximab 10 mg/ml, injektionskoncentrat, flaska 10 ml |
Rituximab 10 mg/mL solution for injection |
| Rituximab 500mg infusion concentrate vial |
Rituximab 10 mg/mL solution for injection |
| Rituximab 500mg injection |
Rituximab 10 mg/mL solution for injection |
| rivastigmin 4,6 mg/24 timmar, depåplåster |
Rivastigmine 192 microgram/hour prolonged-release transdermal patch |
| rivastigmin 9,5 mg/24 timmar, depåplåster |
Rivastigmine 396 microgram/hour prolonged-release transdermal patch |
| Rivermeads ADL-index |
Rivermead Activities of Daily Living Scale (assessment scale) |
| rizatriptan 10 mg, frystorkad tablett |
Rizatriptan only product in oral dose form |
| rizatriptan 10 mg, smälttablett |
Rizatriptan only product in oral dose form |
| Ro phenotype |
cDe haplotype (finding) |
| Robinow-liknande syndrom |
Peters plus syndrome |
| Rochalimea henselae (organism) |
Bartonella henselae |
| Rochalimea quintana (organism) |
Bartonella quintana |
| Rochalimea vinsonii (organism) |
Bartonella vinsonii |
| Rochalimea, NOS (organism) |
Bartonella |
| stavmonokromasi |
Complete achromatopsia |
| romidepsin 10 mg, injektionsvätska, lösning |
Romidepsin 10 mg powder for solution for injection vial |
| ropinirol 3 mg, depåtablett |
Ropinirole only product |
| Ropinirole hydrochloride 3mg tablet |
Product containing precisely ropinirole (as ropinirole hydrochloride) 3 milligram/1 each conventional release oral tablet (clinical drug) |
| Ropinirole hydrochloride 500micrograms tablet |
Ropinirole (as ropinirole hydrochloride) 500 microgram oral tablet |
| ropivakainhydroklorid 2 mg/ml, infusionsvätska, lösning, påse 100 ml |
Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| ropivakainhydroklorid 2 mg/ml, infusionsvätska, lösning, påse 200 ml |
Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| ropivakainhydroklorid 5 mg/ml, injektionsvätska, lösning, ampull |
Product containing only ropivacaine in parenteral dose form (medicinal product form) |
| Rosacea |
Rosacea (disorder) |
| bengalrosa 1 %, ögondroppar |
Rose bengal only product |
| bengalrosa 1 %, ögondroppar för engångsbruk |
Rose bengal only product |
| bengalrosa 1,3 mg, ögonremsa |
Rose bengal only product |
| Roseola virus |
Human herpesvirus 6 |
| Rosiglitazone + rosiglitazone maleate 8mg/ns tablet |
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet |
| Rosiglitazone maleate 2mg tablet |
Product containing precisely rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) |
| ross riverfeber |
Disease caused by Ross River virus (disorder) |
| transplantation av rotationslambå |
Reconstruction using local skin rotation flap (procedure) |
| rotavirusinfektion hos barn |
Viral gastroenteritis due to Rotavirus |
| rundcelligt liposarkom |
Myxoid liposarcoma (disorder) |
| rundcelligt liposarkom |
Myxoid liposarcoma |
| Route of administration of treatment |
Administration of substance via specific route (procedure) |
| Route of administration of treatment |
Administration of substance via specific route (procedure) |
| suddgummi i näsan som orsakar luftvägsobstruktion |
Obstruction of respiratory tract caused by eraser in nose (disorder) |
| Rubella antibody titer NOS |
Rubella antibody titer measurement |
| Rubella antibody titre NOS |
Rubella antibody titer measurement |
| Rubeola virus antibody |
Measles virus antibody |
| Ruminococcus hansenii |
Blautia hansenii (organism) |
| Ruminococcus pasteurii |
Trichococcus pasteurii (organism) |
| Ruminococcus productus |
Blautia producta |
| Rupture of other tendons of foot and ankle, NEC |
Rupture of tendon of foot and ankle |
| ruptur av handledsflexorer |
Rupture of flexor tendon of wrist (disorder) |
| Rusch 10mL balloon 12Ch DT71002 2-way PTFE coated male length urethral Foley catheter |
Urinary catheter |
| Rusch 10mL balloon 18Ch DT71002 2-way PTFE coated male length urethral Foley catheter |
Urinary catheter |
| Rusch 30mL balloon 16Ch DT73002 2-way PTFE coated male length urethral Foley catheter |
Urethral catheter |
| Rusch 30mL balloon 18Ch DT73002 2-way PTFE coated male length urethral Foley catheter |
Urinary catheter |
| Rusch 30mL balloon 18Ch DT83002 2-way PTFE coated female length urethral Foley catheter |
Urinary catheter |
| Rusch 30mL balloon 20Ch DT73002 2-way PTFE coated male length urethral Foley catheter |
Urinary catheter |
| Rusch 30mL balloon 22Ch DT73002 2-way PTFE coated male length urethral Foley catheter |
Urinary catheter |
| Rusch 30mL balloon 22Ch DT83002 2-way PTFE coated female length urethral Foley catheter |
Urinary catheter |
| Rusch 30mL balloon 24Ch DT73002 2-way PTFE coated male length urethral Foley catheter |
Urinary catheter |
| Rusch 30mL balloon 26Ch DT73002 2-way PTFE coated male length urethral Foley catheter |
Urinary catheter |
| Ryska federationen, Asien |
Russian Federation |
| Ryska federationen, Europa |
Russian Federation |
| Rz phenotype |
CDE haplotype (finding) |
| test för SH-antigen vid hepatit B |
Hepatitis B surface antigen measurement |
| SNOMED RT Concept |
SNOMED CT Concept |
| Saccharothrix coeruleoviolacea |
Goodfellowiella coeruleoviolacea (organism) |
| Saccharothrix flava |
Lechevalieria flava (organism) |
| sakrala gropar |
Sacral dimple |
| Saddle-shaped |
Saddle shape |
| trygg miljö |
Safe environment |
| saffran, livsmedel |
Saffron (substance) |
| Salaam spasm |
Epileptic spasms (finding) |
| salaamkramp |
Epileptic spasms (finding) |
| salbutamolsulfat 100 mg/20 ml, lösning för nebulisator |
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for nebulizer (clinical drug) |
| salbutamol 2,5 mg/2,5 ml, för nebulisator |
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for nebulizer (clinical drug) |
| salbutamol 200 mikrogram, andningsaktiverad pulverinhalator |
Salbutamol (as salbutamol sulfate) 200 microgram/actuation powder for inhalation |
| salbutamol 200 mikrogram, inhalationskapsel |
Salbutamol (as salbutamol sulfate) 200 microgram/actuation powder for inhalation |
| salbutamol 400 mikrogram, inhalationskapsel |
Salbutamol 400 microgram/actuation powder for inhalation |
| salbutamol 5 mg/2,5 ml, för nebulisator |
Product containing precisely salbutamol (as salbutamol sulfate) 2 milligram/1 milliliter conventional release solution for nebulizer (clinical drug) |
| salbutamol 5 mg/50 ml, injektion |
Product containing precisely salbutamol (as salbutamol sulfate) 100 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| salbutamol 50 mg/5 ml, intravenös infusion |
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| salbutamol 2,5 mg + ipratropiumbromid 500 mikrogram, för nebulisator |
Salbutamol (as salbutamol sulfate) 2.5 mg/actuation solution for inhalation |
| Salcatonin 200iu nasal spray |
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
| laxkalcitonin 200 IE, nässprej |
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
| Salicoazosulfapyridine |
Product containing sulfasalazine (medicinal product) |
| Salicylamide |
Salicylamide |
| salicylatextrakt |
Product containing salicylate (product) |
| Salicylic acid 17% liquid |
Salicylic acid 170 mg/mL cutaneous solution |
| salicylsyra 17 %, vätska |
Salicylic acid 170 mg/mL cutaneous solution |
| Salicylic acid 17% liquid+pack |
Salicylic acid 170 mg/mL cutaneous solution |
| Salicylic acid 20% 7.5cmx4.5cm plaster |
Product containing only salicylic acid in cutaneous dose form (medicinal product form) |
| salicylsyraplåster 20 %, 7,5 cm x 4,5 cm |
Product containing only salicylic acid in cutaneous dose form (medicinal product form) |
| salicylsyraplåster 40 %, 7,5 cm x 4,5 cm |
Product containing only salicylic acid in cutaneous dose form (medicinal product form) |
| Salicylic acid 40% 7.5cmx4.5cm plaster |
Product containing only salicylic acid in cutaneous dose form (medicinal product form) |
| salicylsyra 1 % + antrakinonglykosider 0,5 %, för pensling i munnen |
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
FHIR